Gavin MacBeath - 25 Jul 2022 Form 4 Insider Report for TScan Therapeutics, Inc. (TCRX)

Role
Chief Scientific and Operations Officer
Signature
/s/ Gavin MacBeath
Issuer symbol
TCRX
Transactions as of
25 Jul 2022
Transactions value $
$0
Form type
4
Date filed
27 Jul 2022, 16:30
Previous filing
20 Jan 2022
Next filing
06 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRX Stock Option (Right to Buy) Award $0 +100K $0.00 100K 25 Jul 2022 Voting Common Stock 100K $3.27 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option vest over 4 years of service following July 25, 2022, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter.

Remarks:

Chief Scientific and Operations Officer